SUBSEQUENT EVENTS (Details Narrative) - USD ($) |
Sep. 10, 2025 |
Jan. 09, 2026 |
Feb. 28, 2025 |
Jan. 22, 2025 |
Dec. 31, 2024 |
Mar. 03, 2024 |
Dec. 31, 2023 |
Nov. 08, 2023 |
|---|---|---|---|---|---|---|---|---|
| Subsequent Event [Line Items] | ||||||||
| Ordinary shares | 14,583,333 | 14,583,333 | ||||||
| Common stock, par value | $ 0.0001 | |||||||
| Warrant term | 5 years | 5 years | ||||||
| Subsequent Event [Member] | ||||||||
| Subsequent Event [Line Items] | ||||||||
| Warrants exercise price | $ 250,000 | |||||||
| Warrant issued | 3,289,490 | |||||||
| Common stock, par value | $ 0.0001 | |||||||
| Warrant term | 3 years | |||||||
| Subsequent Event [Member] | Equity Purchase Agreement [Member] | ||||||||
| Subsequent Event [Line Items] | ||||||||
| Investments | $ 5,000,000 | |||||||
| Ordinary shares | 168,182 | |||||||
| Subsequent Event [Member] | Equity Purchase Agreement [Member] | Williamsburg Venture Holdings LLC [Member] | ||||||||
| Subsequent Event [Line Items] | ||||||||
| Business Combination, Achieved in Stages, Preacquisition Equity Interest in Acquiree, Percentage | 9.99% | |||||||
| Subsequent Event [Member] | Registration Rights Agreement [Member] | ||||||||
| Subsequent Event [Line Items] | ||||||||
| Investments | $ 750,000 | |||||||
| Subsequent Event [Member] | Asset Purchase Agreement [Member] | ||||||||
| Subsequent Event [Line Items] | ||||||||
| Ordinary shares | 1,200,000 | |||||||
| Subsequent Event [Member] | Convertible Loan Agreement [Member] | ||||||||
| Subsequent Event [Line Items] | ||||||||
| Principal amount | $ 1,000,000 | |||||||
| Interest rate | 10.00% | |||||||
| Warrants purchase percentage | 15.00% | |||||||
| Warrants exercise price | $ 2,500 | |||||||
| Additional warrants | $ 10,000 | |||||||
| Credit facility description | The Agreement further provides Theracell with access to a credit facility of up to $10,000,000, available in tranches with the Lender’s prior written approval in its sole discretion. Drawdowns under the facility are subject to the same terms as the Loan, other than the conversion feature. Theracell has drawn $10,000,000 under the credit facility as well as $775,000 paid over and above the $10,000,000 credit line amount as of the date of this annual report on Form 10-K. The previously outstanding debt facilities from Newtech Investment Holdings, LLC and Ariel Malik totaling $6,083,857 were repaid from the proceeds of the facility. The Agreement also provides that, following the lapse of 30 days from the Effective Date and subject to the receipt of all necessary corporate and legal approvals, the Lender may appoint three members to the Company’s Board of Directors, which appointments will be subject to the disclosure and filing requirements of the Securities Exchange Act of 1934 and the rules of the Securities and Exchange Commission. |